CAV1 and systemic sclerosis: We previously demonstrated that monocytes from SSc patients and healthy AA exhibit enhanced fibrogenic differentiation due to a deficiency in caveolin-1 that can be functionally reversed by treating the cells with CSD which serves as a surrogate for caveolin-1 (Reese et al., 2014b; Lee et al., 2015).